Physician profile
Christopher E Sward
NPI 1164587267
$1,293.39
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.31 · 2023: $294 · 2024: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,248.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $196.81 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $161.79 | 2023-2024 | Qulipta, Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $155.70 | 2023-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $154.68 | 2023-2024 | |
| Lilly USA, LLC | $112.04 | 2023-2024 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $81.99 | 2019-2024 | Evenity, Prolia, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.88 | 2024 | Ofev, Jardiance |
| Phathom Pharmaceuticals, INC. | $63.64 | 2024 | Voquezna |
| Axsome Therapeutics, INC. | $55.20 | 2023-2024 | Auvelity |
| Abbott Laboratories | $49.36 | 2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $47.33 | 2024 | Xarelto |
| Optinose US, INC. | $29.40 | 2024 | |
| Ethicon US, LLC | $24.76 | 2019 | |
| Shield Therapeutics INC | $22.63 | 2024 | |
| Idorsia Pharmaceuticals US INC | $19.71 | 2024 | Quviviq |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $14.98 | 2024 | Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $14.52 | 2024 | |
| Scilex Pharmaceuticals INC. | $13.75 | 2024 | |
| Sumitomo Pharma America, INC. | $11.22 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.